Healthy Female Army
No Result
View All Result
  • Healthcare
  • Health and Medicine
  • Health News
  • Staying Healthy
  • Healthcare
  • Health and Medicine
  • Health News
  • Staying Healthy
No Result
View All Result
Healthy Female Army
No Result
View All Result
Home Healthcare

Patent system key to lower drug prices, experts say

by
March 9, 2023
in Healthcare
0
Patent system key to lower drug prices, experts say
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Following the Biden administration’s progress towards lowering prescription drug prices with Medicare price negotiations, some industry advocates want Congress to go a step farther and close patent loopholes which prevent generic varieties of top-selling drugs.

“What we’ve been seeing lately is that companies are filing for dozens or even hundreds of patents to extend their monopoly period in order to keep their revenues, and that’s blocking competition from the market,” Priti Krishtel, co-founder of medicine access nonprofit I-MAK, said.

Patents give companies 20 years of manufacturing exclusivity on their drugs, designed to allow pharmaceutical companies to recoup development costs before the formula can be manufactured on a generic basis. Because of the monopoly patents create, prices of drugs under patent are always higher than those with generic alternatives.

Seven of the ten best selling drugs in the country are due to run out of patent protection within the next decade, causing pharmaceutical companies to scramble to extend their patents any way possible, Krishtel said.

Sen. Tina Smith (D-Minn.) explained that while it will be difficult to pass any major healthcare legislation in a divided Congress, there is some bipartisan support for lowering drug costs. Smith is a member of the Senate Committee on Health, Education, Labor and Pensions (HELP).

“The Senate HELP committee has traditionally worked in strong, bipartisan ways on prescription drugs, on mental health, on supporting community health centers. You always have to look for that place where you can find common ground,” Smith said. “Many of the bills that I’ve introduced to bring more competition to drug pricing are bipartisan bills. I’ve worked with Sen. (Bill) Cassidy (R-La.) … and Sen. (Roger) Marshall (R-Kan.) and others. We have to be optimistic.”

Smith said that despite being passed along partisan lines, the Inflation Reduction Act (IRA), which contains lines capping prescription drug prices for Medicare recipients, is popular among both Democrats and Republicans in her state.

The group spoke at an event hosted by The Hill on Thursday, moderated by The Hill’s Editor in Chief Bob Cusack. The event was sponsored by the Pharmaceutical Care Management Association.

Rep. David Schweikert (R-Ariz.) said a key to any conversation on lowering drug prices is considering how any legislation would impact industry competition. He criticized the IRA price caps, saying they will discourage companies from developing new drugs and calling it a government-sponsored “protection racket.” 

Schweikert instead advocated for “hyper-disruption” in the pharmaceutical sector through financial incentives for manufacturing generic drugs. He praised a new factory being built in Virginia which plans to produce and sell generic insulin for $30 a vial, less than the government price cap for Medicare recipients.

“How do I get almost every company interested into the manufacturing business? How do I almost flood the market with competition?” Schweikert said.

He also advocated for direct-to-consumer drug sales, which could lower purchasing costs for the average American.

Despite signs that some on both sides of the aisle are willing to work towards legislation on this issue, there is little from either party’s leadership that progress is imminent, economic consultant Alex Brill said. Both parties have signaled that any modifications to Social Security or Medicare funding is unlikely in this year’s budget talks.

“The near-term rhetoric, from both parties, doesn’t give me a lot of hope,” Brill said. “There should be a strong desire to say to constituents and patients, ‘We’re going to bring down your healthcare costs,’ … but the headlines are that in the near-term, those policies are off the table.”

“Ultimately, Congress will be forced to address this issue. These are not choices,” he said. “This will become a necessity for Social Security, for Medicare and for others. They are on unsustainable paths and structural changes will be required.” 

Previous Post

Sanders unveils legislation capping insulin costs at $20 per vial

Next Post

FDA releases new regs intended to help detect breast cancer sooner

Next Post
FDA releases new regs intended to help detect breast cancer sooner

FDA releases new regs intended to help detect breast cancer sooner

  • Trending
  • Comments
  • Latest
Vaccine protection against COVID-19 related issues

Vaccine protection against COVID-19 related issues

April 26, 2022
2 in 3 physicians concerned about AI driving diagnosis, treatment decisions: Survey

2 in 3 physicians concerned about AI driving diagnosis, treatment decisions: Survey

October 31, 2023
Religious services may lower risk of ‘deaths of despair’

Religious services may lower risk of ‘deaths of despair’

April 26, 2022
Signaling molecule may prevent Alzheimer’s

Signaling molecule may prevent Alzheimer’s

April 26, 2022
How Trump’s megabill will impact health care 

How Trump’s megabill will impact health care 

0
7 Tips to Make Your Workout Routine More Sustainable

7 Tips to Make Your Workout Routine More Sustainable

0
11 Weight Loss Tips That Will Get you Fast Results

11 Weight Loss Tips That Will Get you Fast Results

0
What are the Sunday Scaries? Plus, Here’s How to Beat Them

What are the Sunday Scaries? Plus, Here’s How to Beat Them

0
How Trump’s megabill will impact health care 

How Trump’s megabill will impact health care 

July 4, 2025
GOP megabill extends and expands compensation for nuclear weapons radiation victims

GOP megabill extends and expands compensation for nuclear weapons radiation victims

July 3, 2025
Supreme Court rebuffs Montana attempt to revive parental consent abortion law

Supreme Court rebuffs Montana attempt to revive parental consent abortion law

July 3, 2025
Senate Democrat: Nation would be ‘sicker, hungrier, and less well-off’ if GOP megabill passes

Senate Democrat: Nation would be ‘sicker, hungrier, and less well-off’ if GOP megabill passes

July 3, 2025

Recent News

How Trump’s megabill will impact health care 

How Trump’s megabill will impact health care 

July 4, 2025
GOP megabill extends and expands compensation for nuclear weapons radiation victims

GOP megabill extends and expands compensation for nuclear weapons radiation victims

July 3, 2025
Supreme Court rebuffs Montana attempt to revive parental consent abortion law

Supreme Court rebuffs Montana attempt to revive parental consent abortion law

July 3, 2025
Senate Democrat: Nation would be ‘sicker, hungrier, and less well-off’ if GOP megabill passes

Senate Democrat: Nation would be ‘sicker, hungrier, and less well-off’ if GOP megabill passes

July 3, 2025
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: Healthyfemalearmy.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
© 2025 Healthyfemalearmy.com. All rights reserved.

No Result
View All Result
  • Contact Us
  • Email Whitelisting
  • Home 1
  • Privacy Policy
  • Terms and Conditions
  • Terms and Conditions

Disclaimer: Healthyfemalearmy.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
© 2025 Healthyfemalearmy.com. All rights reserved.